Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Jean‐Pierre J. Issa, Gail J. Roboz, David A. Rizzieri, Elias Jabbour, Wendy Stock, Casey L. O’Connell, Karen Yee, Raoul Tibes, Elizabeth A. Griffiths, Katherine Walsh,

The Lancet Oncology · 2015 · 281 citations · 16 references

DOIFull text

Open access

Concepts

References

16